Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single‐agent checkpoint blockade

Overview of attention for article published in Clinical and Translational Medicine, October 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 44 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 1,522 followers.

RT @fezziwig2008: #ESMO18 IsturataMAB from $MACK in #PancreaticCancer Failed-Whether #Bispecific or #CheckpointInhibitor-Monoclonal Abs Hav…

Reply Repost Favourite

RT @fezziwig2008: PegpH20 Preconditioning Prior to PD-1 & PD-L1 Inhibition significantly suppressed tumor growth in preclinical #Pancreatic…

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.